Schedule 13G ownership disclosure

Caris Life Sciences Inc

Common Stock, par value $0.001 per share · CUSIP: 142152107

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • J H Whitney VI LP

    Shares: 20,256,615 · Class: 7.3%

  • J. H. Whitney Equity Partners VI, LLC

    Shares: 20,256,615 · Class: 7.3%

  • VIGANO PAUL R

    Shares: 20,256,615 · Class: 7.3%

  • WILLIAMS ROBERT M JR

    Shares: 20,256,615 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-031213
Form type
SCHEDULE 13G
Filer
Caris Life Sciences, Inc.
CIK
CIK 2019410
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub